Michael W. Bonney - 30 Jun 2021 Form 4 Insider Report for Kaleido Biosciences, Inc.

Role
Director
Signature
/s/ Jerald Korn, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
30 Jun 2021
Net transactions value
$0
Form type
4
Filing time
01 Jul 2021, 16:25:22 UTC
Previous filing
14 Jun 2021
Next filing
19 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KLDO Stock Option (Right to Buy) Award $0 +15,000 $0.000000 15,000 30 Jun 2021 Common Stock 15,000 $7.44 Direct
transaction KLDO Stock Option (Right to Buy) Award $0 +15,000 $0.000000 15,000 30 Jun 2020 Common Stock 15,000 $7.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The original Form 4, filed on July 1, 2020, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the exercise price as $7.42 when in fact the exercise price is 7.43.